卵巢交界性肿瘤保留生育功能研究进展  

Research Progress of Fertility-Sparing Treatment of Borderline Ovarian Tumors

作　　者：韩瑛 刘崇东[1] Han Ying;Liu Chongdong(Department of Obstetrics and Gynecology,Bejing Chaoyang Hospital,Capital Medical University,Bejing 100020,China)

机构地区：[1]首都医科大学附属北京朝阳医院妇产科,北京100020

出　　处：《肿瘤预防与治疗》2024年第5期449-453,共5页Journal of Cancer Control And Treatment

摘　　要：卵巢交界性肿瘤(borderline ovarian tumors, BOTs)常见于年轻女性,保留生育功能是治疗过程中需要关注的重要问题之一。保留生育功能手术(fertility-sparing surgery, FSS)可以改善患者的生育相关功能和心理健康,早期BOTs患者可根据组织学亚型和预后因素选择FSS。本文通过综述国内外文献,回顾卵巢交界性肿瘤保留生育功能研究进展,以期为临床治疗提供参考。Borderline ovarian tumors(BOTs)are common in young women,and fertility-sparing treatment is an impor-tant concern.Fertility-sparing surgery(FSS)can improve fertility-related functions and mental health in patients with early BOTs,and FSS can be selected based on histological subtypes and prognostic factors.In this review,we studied the domestic and foreign literature to conclude the research progress of the fertility preservation for women with borderline ovarian tumors,providing guidance for clinical practice.

关 键 词：卵巢交界性肿瘤 保留生育功能 手术治疗 

分 类 号：R737.33[医药卫生—肿瘤] R730.56[医药卫生—临床医学]